Fas and Fas ligand: Expression and soluble circulating levels in bile duct carcinomaMURAKAMI, Masateru; SASAKI, Tamito; MIYATA, Hideki et al.Oncology reports. 2004, Vol 11, Num 6, pp 1183-1186, issn 1021-335X, 4 p.Article

Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cellsTOURNEUR, Léa; MISTOU, Sylvie; MICHIELS, Francine-Marie et al.Oncogene (Basingstoke). 2003, Vol 22, Num 18, pp 2795-2804, issn 0950-9232, 10 p.Article

Efficient expression and primary purification of 6-his tagged human Fas ligand in Dictyostelium discoideumJIE CHEN; YINGHUA LU; ZHINAN XU et al.Biotechnology letters. 2007, Vol 29, Num 6, pp 859-863, issn 0141-5492, 5 p.Article

Geraniin-mediated apoptosis by cleavage of focal adhesion kinase through up-regulation of Fas ligand expression in human melanoma cellsLEE, Jang-Chang; TSAI, Chih-Yen; KAO, Jung-Yie et al.Molecular nutrition & food research (Print). 2008, Vol 52, Num 6, pp 655-663, issn 1613-4125, 9 p.Article

Fas-ligand staining in non-drug- and drug-induced maculopapular rashesWANG, Etienne C. E; LEE, Joyce S. S; TAN, Audrey W. H et al.Journal of cutaneous pathology. 2011, Vol 38, Num 2, pp 196-201, issn 0303-6987, 6 p.Article

Epithelial apoptosis: Cause or consequence of ulcerative colitis?BENEDICT SEIDELIN, Jakob; HAAGEN NIELSEN, Ole.Scandinavian journal of gastroenterology. 2009, Vol 44, Num 12, pp 1429-1434, issn 0036-5521, 6 p.Article

Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruptionCHOI, H. J; KU, J. K; KIM, M. Y et al.British journal of dermatology (1951). 2006, Vol 154, Num 3, pp 419-425, issn 0007-0963, 7 p.Article

Development of immunomodulatory six base-length non-CpG motif oligonucleotides for cancer vaccinationFILION, Mario C; FILION, Benoit; ROY, Julie et al.Vaccine. 2004, Vol 22, Num 19, pp 2480-2488, issn 0264-410X, 9 p.Conference Paper

Soluble Fas (sFas) and soluble Fas ligand (sFas-L) balance in laryngeal carcinoma before and after surgical treatmentPIGNATARO, Lorenzo; ARISI, Elena; SAMBATARO, Giuseppe et al.Journal of surgical oncology. 2003, Vol 83, Num 2, pp 112-115, issn 0022-4790, 4 p.Article

Production, purification and cytotoxity of soluble human Fas ligand expressed by Escherichia coli and Dictyostelium discoideumZHEN LUO; ZHINAN XU; SHANLING ZHUO et al.Biochemical engineering journal. 2012, Vol 62, pp 86-91, issn 1369-703X, 6 p.Article

Trophoblast Apoptosis in Placentas from Pregnancies Complicated by PreeclampsiaTOMAS, S. Z; PRUSAC, I. K; ROJE, D et al.Gynecologic and obstetric investigation. 2011, Vol 71, Num 4, pp 250-255, issn 0378-7346, 6 p.Article

The role of Fas ligand and transforming growth factor β in tumor progression: Molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapyKIM, Ryungsa; EMI, Manabu; TANABE, Kazuaki et al.Cancer. 2004, Vol 100, Num 11, pp 2281-2291, issn 0008-543X, 11 p.Article

Prognostic implications of Fas-ligand expression in nasopharyngeal carcinomaHO, Sheng-Yow; GUO, How-Ran; CHEN, Helen H. W et al.Head & neck. 2004, Vol 26, Num 11, pp 977-983, issn 1043-3074, 7 p.Article

Examination of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients with burnsYAMADA, Yasuhiko; ENDO, Shigeatsu; NAKAE, Hajime et al.Burns. 2003, Vol 29, Num 8, pp 799-802, issn 0305-4179, 4 p.Article

TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 miceWILHELM, Patricia; WIEDE, Florian; MEISSNER, Anja et al.Microbes and infection. 2005, Vol 7, Num 15, pp 1461-1468, issn 1286-4579, 8 p.Article

Local adenoviral expression of Fas ligand upregulates pro-inflammatory immune responses in the CNSREGARDSOE, E. L; MCMENAMIN, M. M; CHARLTON, H. M et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 19, pp 1462-1474, issn 0969-7128, 13 p.Article

Fas-mediated apoptosis in acute alcoholic hepatitisTAGAMI, Atsushi; OHNISHI, Hiroo; MORIWAKI, Hisataka et al.Hepato-gastroenterology. 2003, Vol 50, Num 50, pp 443-448, issn 0172-6390, 6 p.Article

Polymorphisms of FAS and FAS ligand genes in preeclamptic womenCIARMELA, Pasquapina; BOSCHI, Sonia; BLOISE, Enrrico et al.European journal of obstetrics, gynecology, and reproductive biology. 2010, Vol 148, Num 2, pp 144-146, issn 0301-2115, 3 p.Article

Secondary Apoptosis of Spiral Ganglion Cells Induced by Aminoglycoside : Fas-Fas Ligand Signaling PathwayWOO YONG BAE; LEE SUK KIM; DAE YOUNG HUR et al.The Laryngoscope. 2008, Vol 118, Num 9, pp 1659-1668, issn 0023-852X, 10 p.Article

Fas-ligand gene silencing in basal cell carcinoma tissue with small interfering RNAJI, J; WERNLI, M; MIELGO, A et al.Gene therapy (Basingstoke). 2005, Vol 12, Num 8, pp 678-684, issn 0969-7128, 7 p.Article

Circulating levels of soluble fas ligand in cachexic patients with COPD are higher than those in non-cachexic patients with COPDTAKABATAKE, Noriaki; ARAO, Tsuyoshi; SATA, Makoto et al.Internal medicine (Tokyo. 1992). 2005, Vol 44, Num 11, pp 1137-1143, issn 0918-2918, 7 p.Article

Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cellsMODIANO, Jaime F; SUN, Juan; BELLGRAU, Donald et al.Clinical immunology (Orlando, Fla. Print). 2004, Vol 112, Num 1, pp 54-65, issn 1521-6616, 12 p.Article

Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHTWROBLEWSKI, Victor J; WITCHER, Derrick R; HALE, John E et al.Biochemical pharmacology. 2003, Vol 65, Num 4, pp 657-667, issn 0006-2952, 11 p.Article

The FAS ligand promoter polymorphism, rs763110 (-844C > T), contributes to cancer susceptibility: evidence from 19 case-control studiesZHIZHONG ZHANG; LIXIN QIU; MEILIN WANG et al.European journal of human genetics. 2009, Vol 17, Num 10, pp 1294-1303, issn 1018-4813, 10 p.Article

Differential regulation and function of the Fas/Fas ligand system in human trophoblast cellsASCHKENAZI, Sarit; STRASZEWSKI, Shawn; VERWER, Karlijn M. A et al.Biology of reproduction. 2002, Vol 66, Num 6, pp 1853-1861, issn 0006-3363Article